The University of Chicago Header Logo

Atman Shah

Concepts (392)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cardiac Catheterization
18
2024
316
4.560
Why?
Heart-Assist Devices
11
2018
822
2.760
Why?
Septal Occluder Device
14
2024
51
2.640
Why?
Shock, Cardiogenic
6
2024
124
2.570
Why?
Heart Arrest
14
2024
280
2.280
Why?
Aortic Valve Insufficiency
5
2017
136
2.060
Why?
Cardiopulmonary Resuscitation
10
2024
224
1.940
Why?
Myocardial Infarction
11
2024
385
1.930
Why?
Ventricular Fibrillation
10
2016
68
1.880
Why?
Myocardial Ischemia
8
2024
165
1.790
Why?
Heart Valve Prosthesis Implantation
7
2023
182
1.720
Why?
Echocardiography, Transesophageal
14
2024
357
1.720
Why?
Extracorporeal Membrane Oxygenation
6
2024
197
1.660
Why?
Ventricular Function, Left
9
2021
617
1.660
Why?
Absorbable Implants
4
2021
37
1.540
Why?
Aortic Valve
5
2023
251
1.530
Why?
Aortic Valve Stenosis
6
2023
149
1.510
Why?
Coronary Vessels
8
2024
194
1.510
Why?
Heart Septal Defects, Ventricular
3
2019
70
1.470
Why?
Coronary Angiography
16
2024
246
1.440
Why?
Popliteal Artery
3
2021
29
1.430
Why?
Peripheral Arterial Disease
3
2021
98
1.420
Why?
Angioplasty, Balloon
2
2020
98
1.330
Why?
Heart Failure
9
2021
1270
1.320
Why?
Treatment Outcome
40
2024
8367
1.310
Why?
Ischemia
2
2020
254
1.190
Why?
Coronary Artery Disease
8
2024
373
1.160
Why?
Percutaneous Coronary Intervention
7
2020
69
1.140
Why?
Foramen Ovale, Patent
2
2021
19
1.120
Why?
Angioplasty, Balloon, Coronary
9
2012
67
1.080
Why?
Prosthesis Design
11
2024
307
1.050
Why?
Cardiac Surgical Procedures
5
2019
482
1.050
Why?
Endothelin-1
3
2011
40
0.990
Why?
Practice Guidelines as Topic
5
2019
1054
0.960
Why?
Out-of-Hospital Cardiac Arrest
4
2020
94
0.940
Why?
Ultrasonography, Interventional
3
2023
126
0.930
Why?
Stents
5
2024
415
0.900
Why?
Echocardiography, Three-Dimensional
7
2020
521
0.900
Why?
Male
61
2024
42909
0.890
Why?
Humans
86
2024
90539
0.880
Why?
Hypothermia, Induced
1
2024
82
0.860
Why?
Hemodynamics
6
2024
739
0.840
Why?
Catheterization
5
2017
239
0.800
Why?
Registries
7
2024
812
0.800
Why?
Pulmonary Embolism
6
2021
237
0.780
Why?
Middle Aged
35
2024
26305
0.780
Why?
Arrhythmias, Cardiac
2
2017
201
0.750
Why?
Endovascular Procedures
2
2017
295
0.750
Why?
Transcatheter Aortic Valve Replacement
2
2019
58
0.740
Why?
Thrombolytic Therapy
5
2021
246
0.740
Why?
Aged
33
2024
19380
0.740
Why?
Electrocardiography
6
2021
498
0.690
Why?
Secondary Prevention
1
2021
162
0.690
Why?
Heart Diseases
5
2021
306
0.670
Why?
Platelet Aggregation Inhibitors
1
2021
149
0.660
Why?
Female
47
2024
46831
0.650
Why?
Coronary Artery Bypass
4
2023
239
0.650
Why?
Retrospective Studies
25
2023
9310
0.650
Why?
Heart Ventricles
3
2020
791
0.610
Why?
Hospital Costs
1
2019
111
0.600
Why?
Acute Coronary Syndrome
1
2018
31
0.590
Why?
Vena Cava, Superior
1
2018
60
0.580
Why?
Clinical Protocols
1
2018
158
0.580
Why?
Balloon Occlusion
3
2012
30
0.570
Why?
Coronary Vessel Anomalies
1
2018
41
0.570
Why?
Arteriovenous Fistula
1
2018
53
0.570
Why?
Computed Tomography Angiography
2
2020
155
0.570
Why?
Blood Circulation
1
2017
30
0.570
Why?
Heart Massage
1
2017
12
0.560
Why?
Venae Cavae
1
2017
12
0.560
Why?
Atrial Appendage
3
2024
35
0.560
Why?
Mitral Valve
6
2020
267
0.560
Why?
Prosthesis Failure
2
2017
119
0.560
Why?
Swine
13
2016
593
0.560
Why?
Transposition of Great Vessels
1
2017
24
0.560
Why?
Prosthesis Implantation
1
2018
129
0.560
Why?
Aminophylline
1
2016
14
0.550
Why?
Device Removal
1
2018
169
0.550
Why?
Bradycardia
1
2016
39
0.550
Why?
Atrial Fibrillation
4
2024
360
0.540
Why?
Heart Septal Defects
1
2016
32
0.540
Why?
Fibrinolytic Agents
3
2021
231
0.530
Why?
Dyspnea
1
2016
76
0.530
Why?
Cardiomyopathies
2
2018
269
0.530
Why?
Constriction, Pathologic
1
2017
222
0.520
Why?
Balloon Valvuloplasty
1
2015
8
0.510
Why?
Organ Dysfunction Scores
1
2016
28
0.510
Why?
Postoperative Complications
3
2017
2341
0.510
Why?
Disease Management
1
2018
332
0.510
Why?
Vascular Fistula
1
2015
12
0.500
Why?
Stroke
2
2024
1002
0.500
Why?
Surgery, Computer-Assisted
1
2016
99
0.490
Why?
Mitral Valve Insufficiency
5
2020
198
0.490
Why?
Defibrillators, Implantable
1
2017
146
0.490
Why?
Fontan Procedure
1
2015
56
0.490
Why?
Ventricular Dysfunction, Right
2
2020
146
0.480
Why?
Time Factors
12
2021
5364
0.470
Why?
Ventricular Septum
1
2014
14
0.470
Why?
Heart Injuries
1
2014
20
0.470
Why?
Pulmonary Veins
1
2015
93
0.460
Why?
Iatrogenic Disease
1
2014
71
0.460
Why?
Epinephrine
2
2011
89
0.460
Why?
Adenosine
1
2016
242
0.450
Why?
Aneurysm, False
1
2014
55
0.440
Why?
Risk Assessment
10
2020
2335
0.440
Why?
Echocardiography, Doppler, Color
4
2015
105
0.430
Why?
Aortic Aneurysm, Thoracic
1
2014
89
0.410
Why?
Embolization, Therapeutic
1
2015
265
0.400
Why?
Heart Defects, Congenital
1
2015
367
0.400
Why?
Biomarkers
4
2019
1797
0.390
Why?
Vascular Patency
3
2021
131
0.380
Why?
Aged, 80 and over
10
2020
6808
0.380
Why?
Tissue Plasminogen Activator
1
2013
176
0.380
Why?
Thymosin
1
2011
6
0.370
Why?
Coronary Aneurysm
1
2011
16
0.370
Why?
Polytetrafluoroethylene
1
2011
75
0.360
Why?
Electric Countershock
2
2011
55
0.360
Why?
Death, Sudden, Cardiac
1
2011
54
0.360
Why?
Respiratory Insufficiency
1
2012
163
0.350
Why?
Coronary Disease
2
2012
261
0.350
Why?
Ventricular Pressure
3
2021
43
0.350
Why?
Myocarditis
1
2010
52
0.340
Why?
Severity of Illness Index
7
2019
1882
0.340
Why?
Coronary Thrombosis
2
2017
15
0.340
Why?
Stem Cell Transplantation
1
2011
190
0.330
Why?
Disease Models, Animal
10
2016
2407
0.330
Why?
Drug-Eluting Stents
3
2017
19
0.320
Why?
Obesity, Morbid
1
2012
241
0.320
Why?
After-Hours Care
1
2008
8
0.320
Why?
Vascular Endothelial Growth Factor A
1
2011
407
0.320
Why?
Predictive Value of Tests
7
2018
1741
0.310
Why?
Thrombosis
3
2016
312
0.300
Why?
Follow-Up Studies
6
2024
3691
0.300
Why?
Risk Factors
10
2021
5578
0.300
Why?
Adult
13
2024
26922
0.300
Why?
United States
8
2024
7138
0.300
Why?
Medical Errors
1
2008
115
0.290
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2007
11
0.290
Why?
Coronary Circulation
3
2024
131
0.280
Why?
Hypoxia
1
2012
660
0.280
Why?
Thrombectomy
1
2008
193
0.260
Why?
Circadian Rhythm
1
2008
305
0.260
Why?
Quality Assurance, Health Care
1
2007
225
0.250
Why?
Artifacts
1
2007
246
0.250
Why?
Saphenous Vein
3
2010
62
0.240
Why?
Health Services Accessibility
1
2008
438
0.240
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2008
380
0.240
Why?
Intra-Aortic Balloon Pumping
2
2015
82
0.230
Why?
Diagnosis, Computer-Assisted
1
2007
332
0.230
Why?
Peripheral Vascular Diseases
1
2004
62
0.230
Why?
Hyperlipidemias
1
2004
92
0.230
Why?
Cost-Benefit Analysis
2
2019
471
0.230
Why?
Carotid Arteries
1
2024
135
0.220
Why?
Stroke Volume
4
2021
481
0.220
Why?
Heart Transplantation
2
2023
744
0.220
Why?
Cysteine
1
2024
145
0.210
Why?
Vascular Diseases
1
2024
120
0.210
Why?
Clinical Competence
1
2008
796
0.210
Why?
Osteosarcoma
1
2003
163
0.200
Why?
Microcirculation
2
2024
105
0.200
Why?
Ulnar Artery
1
2022
5
0.200
Why?
Coronary Restenosis
4
2017
12
0.200
Why?
Antibodies, Monoclonal
4
2013
1397
0.200
Why?
Survival Rate
5
2019
1899
0.200
Why?
Tumor Necrosis Factor-alpha
4
2013
705
0.200
Why?
Radial Artery
1
2022
33
0.200
Why?
Cardiovascular Diseases
2
2007
722
0.190
Why?
Feasibility Studies
1
2024
791
0.190
Why?
Hospitals
2
2021
308
0.190
Why?
Aorta
2
2020
291
0.190
Why?
Pilot Projects
1
2024
878
0.180
Why?
Echocardiography
5
2020
947
0.180
Why?
Bone Neoplasms
1
2003
321
0.180
Why?
Everolimus
1
2021
36
0.180
Why?
Gene Expression Regulation
2
2009
1991
0.180
Why?
Heart Atria
3
2016
285
0.180
Why?
Acute Disease
3
2021
854
0.180
Why?
Heart Valve Prosthesis
2
2019
100
0.180
Why?
Anticoagulants
2
2021
440
0.180
Why?
Transillumination
1
2020
9
0.180
Why?
Limb Salvage
1
2020
37
0.180
Why?
Cardiology
1
2021
118
0.180
Why?
Prognosis
5
2024
3810
0.170
Why?
Reoperation
2
2013
610
0.170
Why?
Tomography, X-Ray Computed
6
2017
2692
0.170
Why?
Ultrasonography
3
2015
722
0.170
Why?
Graft Occlusion, Vascular
2
2010
100
0.170
Why?
ST Elevation Myocardial Infarction
1
2020
15
0.170
Why?
Matrix Metalloproteinase 9
2
2011
86
0.170
Why?
Mobile Applications
1
2021
72
0.170
Why?
Resuscitation
2
2011
111
0.160
Why?
Recovery of Function
2
2018
305
0.160
Why?
Animals
14
2016
27690
0.160
Why?
Health Equity
1
2021
97
0.160
Why?
Ischemic Attack, Transient
1
2021
183
0.160
Why?
Fluoroscopy
1
2019
130
0.160
Why?
Venous Thrombosis
1
2021
260
0.160
Why?
Reproducibility of Results
6
2018
2782
0.160
Why?
Echocardiography, Doppler, Pulsed
1
2018
24
0.150
Why?
Quality-Adjusted Life Years
1
2019
145
0.150
Why?
Atrial Function, Left
1
2018
53
0.150
Why?
Monocytes
1
2019
222
0.150
Why?
Microvessels
1
2018
69
0.150
Why?
Recurrence
2
2012
1162
0.140
Why?
Glomerular Filtration Rate
1
2018
279
0.140
Why?
Arterial Switch Operation
1
2017
5
0.140
Why?
Databases, Factual
2
2019
875
0.140
Why?
Communication
1
2021
462
0.140
Why?
Triage
1
2018
118
0.140
Why?
Purinergic P1 Receptor Antagonists
1
2016
6
0.140
Why?
Purinergic P2Y Receptor Antagonists
1
2016
6
0.140
Why?
Renal Veins
1
2017
29
0.140
Why?
Minimally Invasive Surgical Procedures
2
2016
259
0.140
Why?
Tumor Necrosis Factors
1
2016
14
0.140
Why?
Vascular Surgical Procedures
1
2018
150
0.140
Why?
Echocardiography, Doppler
1
2017
188
0.130
Why?
Foreign-Body Migration
1
2017
40
0.130
Why?
Decision Support Techniques
1
2018
170
0.130
Why?
Bioprosthesis
1
2016
39
0.130
Why?
Emergency Service, Hospital
3
2016
532
0.130
Why?
Chronic Disease
1
2019
959
0.130
Why?
Macrophages
1
2019
585
0.130
Why?
Cannula
1
2016
52
0.130
Why?
Equipment Failure
1
2016
123
0.130
Why?
Subclavian Artery
1
2015
43
0.120
Why?
Vena Cava Filters
1
2017
100
0.120
Why?
Ventricular Dysfunction, Left
1
2018
333
0.120
Why?
Length of Stay
1
2019
756
0.120
Why?
Acute Kidney Injury
1
2018
319
0.120
Why?
Fatal Outcome
2
2016
298
0.120
Why?
Random Allocation
4
2020
327
0.120
Why?
Comorbidity
2
2015
955
0.110
Why?
Hyperthermia, Induced
1
2014
73
0.110
Why?
Aortography
1
2014
65
0.110
Why?
California
3
2010
151
0.110
Why?
Blood Transfusion, Autologous
1
2013
16
0.110
Why?
Contrast Media
1
2018
1085
0.110
Why?
Infusions, Parenteral
1
2013
51
0.110
Why?
Amiodarone
1
2013
14
0.110
Why?
Magnetic Resonance Imaging
2
2017
3485
0.110
Why?
Kidney
1
2018
1150
0.110
Why?
L-Lactate Dehydrogenase
1
2013
71
0.110
Why?
International Normalized Ratio
1
2013
39
0.110
Why?
Dobutamine
1
2013
61
0.110
Why?
Diagnosis, Differential
2
2010
1607
0.110
Why?
Pulsatile Flow
1
2013
51
0.100
Why?
Anti-Arrhythmia Agents
1
2013
65
0.100
Why?
Software
1
2017
669
0.100
Why?
Heart
2
2020
580
0.100
Why?
Catheter Ablation
1
2015
255
0.100
Why?
Pulmonary Wedge Pressure
1
2013
116
0.100
Why?
Renal Insufficiency, Chronic
2
2018
229
0.100
Why?
Survival Analysis
1
2016
1499
0.100
Why?
Whole Blood Coagulation Time
1
2012
7
0.100
Why?
Algorithms
2
2017
1918
0.100
Why?
Image Interpretation, Computer-Assisted
1
2017
697
0.100
Why?
Exercise Test
1
2013
168
0.100
Why?
Patient Care Team
1
2014
285
0.100
Why?
Mitral Valve Stenosis
1
2012
38
0.100
Why?
Labetalol
1
2011
6
0.100
Why?
Metoprolol
1
2011
15
0.100
Why?
Vascular Resistance
2
2024
103
0.090
Why?
Radiography, Interventional
1
2012
157
0.090
Why?
Adrenergic beta-Antagonists
1
2011
106
0.090
Why?
Randomized Controlled Trials as Topic
1
2015
845
0.090
Why?
Catheters
2
2021
87
0.090
Why?
Point-of-Care Systems
1
2012
146
0.090
Why?
Regenerative Medicine
1
2011
26
0.090
Why?
Immunoglobulin G
1
2013
472
0.090
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2013
243
0.090
Why?
Creatine Kinase
1
2010
53
0.090
Why?
Infliximab
4
2013
159
0.090
Why?
Vasopressins
1
2010
50
0.090
Why?
Liver Function Tests
1
2010
93
0.090
Why?
Troponin
1
2010
25
0.090
Why?
Monitoring, Physiologic
1
2012
265
0.090
Why?
Proteinuria
1
2010
68
0.090
Why?
Lactic Acid
1
2010
95
0.090
Why?
Patient Selection
3
2020
682
0.090
Why?
Ventricular Remodeling
1
2011
108
0.090
Why?
Blood Pressure
2
2013
906
0.090
Why?
Coronary Sinus
1
2010
10
0.090
Why?
Critical Illness
1
2012
315
0.080
Why?
Prospective Studies
4
2018
4345
0.080
Why?
Sirolimus
1
2010
164
0.080
Why?
Endothelin-2
1
2008
1
0.080
Why?
Endothelin-3
1
2008
2
0.080
Why?
Ventricular Premature Complexes
1
2008
8
0.080
Why?
Electric Stimulation
1
2010
365
0.080
Why?
Paclitaxel
1
2010
484
0.080
Why?
Sensitivity and Specificity
2
2017
2019
0.080
Why?
Reperfusion Injury
1
2009
146
0.080
Why?
Up-Regulation
1
2011
728
0.080
Why?
Heart Rate
1
2010
496
0.070
Why?
Chicago
1
2013
1441
0.070
Why?
Hypertension, Pulmonary
1
2012
370
0.070
Why?
Diastole
2
2018
144
0.070
Why?
Fatigue
1
2008
176
0.070
Why?
Workload
1
2008
130
0.070
Why?
Personnel Staffing and Scheduling
1
2008
97
0.070
Why?
Selection Bias
1
2007
36
0.070
Why?
Myocardium
1
2010
574
0.070
Why?
Cell Movement
1
2011
793
0.070
Why?
Anticholesteremic Agents
1
2008
141
0.070
Why?
Guideline Adherence
1
2008
232
0.070
Why?
Coated Materials, Biocompatible
1
2005
30
0.060
Why?
Cytokines
1
2009
813
0.060
Why?
Coronary Stenosis
1
2005
39
0.060
Why?
Observer Variation
1
2007
615
0.060
Why?
Metals
1
2005
95
0.060
Why?
Immunosuppressive Agents
1
2010
984
0.060
Why?
Action Potentials
1
2008
602
0.060
Why?
Cell Differentiation
1
2011
1547
0.060
Why?
Health Knowledge, Attitudes, Practice
1
2008
539
0.060
Why?
Attitude of Health Personnel
1
2008
651
0.050
Why?
Treatment Failure
1
2024
281
0.050
Why?
Caspases
1
2003
155
0.050
Why?
Blood Vessel Prosthesis Implantation
1
2005
228
0.050
Why?
Young Adult
1
2015
6412
0.050
Why?
Muscle, Smooth, Vascular
1
2003
241
0.050
Why?
Spasm
1
2022
17
0.050
Why?
Preoperative Care
2
2015
400
0.050
Why?
Case-Control Studies
2
2018
1873
0.050
Why?
Lower Extremity
1
2021
89
0.050
Why?
Pulmonary Valve
1
2020
33
0.040
Why?
Cardiac Output
1
2020
154
0.040
Why?
Tissue Donors
1
2023
511
0.040
Why?
Chi-Square Distribution
2
2010
360
0.040
Why?
Organ Size
1
2020
374
0.040
Why?
Prevalence
1
2023
1251
0.040
Why?
Hemorrhage
1
2021
290
0.040
Why?
Protective Factors
1
2018
23
0.040
Why?
Hospital Mortality
1
2021
416
0.040
Why?
Odds Ratio
1
2020
680
0.040
Why?
Proportional Hazards Models
2
2010
842
0.040
Why?
Tricuspid Valve
1
2018
101
0.040
Why?
Antigens, CD
1
2019
467
0.040
Why?
Diffusion of Innovation
1
2017
74
0.040
Why?
Equipment Design
1
2018
423
0.040
Why?
Prosthesis Fitting
1
2017
17
0.040
Why?
Anti-Inflammatory Agents
2
2010
348
0.030
Why?
Apoptosis
1
2003
1723
0.030
Why?
Phlebography
1
2017
70
0.030
Why?
Healthcare Disparities
1
2021
433
0.030
Why?
Illinois
1
2018
491
0.030
Why?
Quality of Life
1
2004
1687
0.030
Why?
Oxygen
1
2021
747
0.030
Why?
Health Status
1
2018
370
0.030
Why?
Consensus
1
2017
371
0.030
Why?
Health Care Surveys
1
2016
279
0.030
Why?
Clinical Decision-Making
1
2017
283
0.030
Why?
Program Evaluation
1
2016
311
0.030
Why?
Evidence-Based Medicine
1
2017
440
0.030
Why?
Ultrafiltration
1
2013
13
0.030
Why?
Random Amplified Polymorphic DNA Technique
1
2013
6
0.030
Why?
Image Enhancement
1
2017
566
0.030
Why?
Jehovah's Witnesses
1
2013
21
0.030
Why?
Lidocaine
1
2013
65
0.030
Why?
Etanercept
1
2013
33
0.030
Why?
Heart Arrest, Induced
1
2013
29
0.030
Why?
Receptors, Tumor Necrosis Factor
1
2013
90
0.030
Why?
Hemoglobins
1
2013
195
0.030
Why?
Cardiopulmonary Bypass
1
2013
160
0.030
Why?
Vasodilator Agents
1
2013
145
0.030
Why?
Reference Values
1
2013
662
0.020
Why?
Sus scrofa
1
2011
51
0.020
Why?
Confidence Intervals
1
2011
220
0.020
Why?
Statistics, Nonparametric
1
2011
303
0.020
Why?
Practice Patterns, Physicians'
1
2016
604
0.020
Why?
Adrenergic Antagonists
1
2010
3
0.020
Why?
Adolescent
1
2003
9341
0.020
Why?
Interleukin-1beta
1
2010
82
0.020
Why?
Creatinine
1
2010
295
0.020
Why?
Inflammation Mediators
1
2009
155
0.020
Why?
Cardiology Service, Hospital
1
2008
4
0.020
Why?
Age Factors
1
2013
1871
0.020
Why?
Models, Animal
1
2009
278
0.020
Why?
False Positive Reactions
1
2008
223
0.020
Why?
Kaplan-Meier Estimate
1
2010
854
0.020
Why?
Disease-Free Survival
1
2010
1170
0.020
Why?
Inflammation
1
2013
990
0.020
Why?
Sex Factors
1
2009
1074
0.020
Why?
Dilatation, Pathologic
1
2006
55
0.020
Why?
Emergency Medical Services
1
2008
245
0.020
Why?
Amino Acid Chloromethyl Ketones
1
2003
25
0.010
Why?
Caspase Inhibitors
1
2003
33
0.010
Why?
Analysis of Variance
1
2006
898
0.010
Why?
Tunica Intima
1
2003
60
0.010
Why?
Hyperplasia
1
2003
153
0.010
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2006
476
0.010
Why?
Rabbits
1
2003
641
0.010
Why?
Incidence
1
2005
1593
0.010
Why?
Shah's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (392)
Explore
_
Co-Authors (45)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_